a

Exactech receives $737M offer from TPG Capital to purchase the company: 3 notes Featured

By  Mackenzie Garrity | Monday, 04 December 2017 21:29
Social sharing

TPG Capital offered Exactech $737 million to buy the medical device company, an increase to its initial offer in October, according to Reuters.

Here are three notes:

 

1. The $49.25 per share offer from TPG Capital is a 17.3 percent increase to its $42 per share offer in October.

 

2. Exatech's board agreed to the amended terms and expects to close the all-cash deal during the first quarter of 2018.

 

3. When the deal was announced Oct. 23, Exatech's stock has hovered at $42. However, on Monday, Dec. 4, the company's stock was trading at $49.25.

 

More articles on devices and implants:
Global spinal fusion devices market to reach nearly $11B by 2025: 6 observations
Mazor Robotics CEO under investigation for insider trading: 3 things to know
Precision Medical opens 3rd Indiana location — 6 notes

© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months